<DOC>
	<DOCNO>NCT00232947</DOCNO>
	<brief_summary>The goal study determine whether immune response induced Fluviral , investigational vaccine , comparable induced Fluzone , influenza vaccine currently license U.S . The study focus person 50 year old . In addition , study compare rate reaction two vaccine , general health person receive 42 day immunization .</brief_summary>
	<brief_title>Study Comparing Immune Response , Safety , Fluviral Fluzone Influenza Vaccines Persons 50 y.o . Over</brief_title>
	<detailed_description>Yearly influenza epidemic responsible excess hospitalization death elderly population , also cause lose work productivity among healthy , work elderly . Fluviral , product license Canada , test determine whether active cause immune response , safe currently license U.S. vaccine person 50 y.o . .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Stable health status Access consistent mean telephone contact . Comprehension study requirement , availability study duration Availability ability attend schedule visit Females post menopausal , sterile use accepted contraceptive measure Competence provide inform consent Presence significant acute chronic medical neuropsych . illness New medical surgical treatment w/i 1 month Change medication dose due uncontrolled symptom w/i 1 month Hospitalization w/i 1 month Any unusual risk ( age group ) serious adverse event w/i 1 month Any neuropsychiatric condition alter competence consent Any neuropsychiatric condition prevent accurate safety report Febrile illness day treatment Employment profession high risk influenza transmission Residence longtermcare facility immunocompromised person Systolic BP 150 , diastolic 90 , rest pulse 50 100 Cancer w/i 3 year Immunosuppressive immunodeficient condition Treatment systemic glucocorticoid &gt; replacement Treatment cytotoxic immunosuppressant drug Treatment immune globulin Clotting disorder increase risk intramuscular injection History demyelinate disease GBS Pregnancy nurse Absence contraceptive practice woman childbearing potential Planned administration noninfluenza vaccine within 30 day Receipt investigational drug within 30 day Receipt immune globulin treatment within 3 month Known suspected allergy egg protein , gelatin , thimerosal History severe adverse reaction toflu vaccine Prior receipt 20056 influenza vaccine</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>vaccine</keyword>
	<keyword>elderly</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>safety</keyword>
</DOC>